Kristin Cardwell

founder, consultant, advisor | business, growth & brand development | consumer + digital | former vp refinery29, l'oreal

📍 London, England Metropolitan Area, United Kingdom🔄 Updated October 2026💼 1 investments📅 7 years investing🗓 Last invested Apr 2019𝕏 @upgrade_to_unlock
VC🌍 United Kingdom
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
7y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor & Advisor
Apr 2019
Daye is a female-founded gynae health start-up on a mission to close the gender health gap for good. We started out with the invention of the world’s first pain-relieving tampon, designed to support the 90% of women who experience menstrual cramps. After helping over 75,000 women & AFAB individuals kick period pain to the curb, we launched our second generation tampon to facilitate the at-home detection of vaginal infections, STIs and HPV. Next, we want to develop solutions for under-served gynae health conditions like endometriosis, PCOS and menopause. Within the next five years, we will build an ecosystem where every woman can understand, monitor, and improve her health from her smartphone.
early stagePublic Health
Experience · 4 entries
All (4)
Investments (1)
Founder (1)
2019
Co-Founder
Nov 2019
Alma Angels is a diverse and active community with a bold mission: Generate $1 trillion in women-led wealth by 2050. Since 2020, we have brought together and trained over 500 angel investors who have invested into 200+ women (co)founders building tech or IP-rich ventures with global ambitions. These companies have gone on to raise more than £300m to date. Alma Angels is committed to training 10,000 angels and backing 10,000 women founders by 2035.
Various
Consultant / Advisor for startups & scale-ups: business & go-to-market strategy, brand, partnerships
Sep 2019
Angel Investor & Advisor
Apr 2019
Daye is a female-founded gynae health start-up on a mission to close the gender health gap for good. We started out with the invention of the world’s first pain-relieving tampon, designed to support the 90% of women who experience menstrual cramps. After helping over 75,000 women & AFAB individuals kick period pain to the curb, we launched our second generation tampon to facilitate the at-home detection of vaginal infections, STIs and HPV. Next, we want to develop solutions for under-served gynae health conditions like endometriosis, PCOS and menopause. Within the next five years, we will build an ecosystem where every woman can understand, monitor, and improve her health from her smartphone.
early stagePublic Health
2012
Various: Techstars, NYU Poly School of Engineering, CFDA, MACHINE, Interbrand, Dagne Dover
Consultant: Business, Brand, Innovation, Growth (During full time MBA)
Sep 2012